
TruAlt Bioenergy IPO Subscription
ListedUpdated 3 October 2025, 9:15 AM IST· Mainboard
TruAlt Bioenergy IPO subscription closed on 29 September 2025 at 75.02x overall by shares. QIB demand came in at 165.16x, NII at 103.04x, and retail at 11.50x. See Retail, SHNI, and BHNI allotment chances in the table…
TruAlt Bioenergy IPO subscription closed on 29 September 2025 at 75.02x overall by shares. QIB demand came in at 165.16x, NII at 103.04x, and retail at 11.50x. See Retail, SHNI, and BHNI allotment chances in the table below.
Show moreShow less
Allotment date is 30 September 2025. Listing date on NSE and BSE is 3 October 2025.
TruAlt Bioenergy IPO Day-wise Subscription
Daily QIB, NII, Retail, and overall subscription as bids come in
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 25 Sept 2025 | 0.89x | 0.25x | 0.31x | 0.46x |
| Day 2 - 26 Sept 2025 | 0.90x | 0.84x | 0.83x | 0.85x |
| Day 3 - 29 Sept 2025 | 165.16x | 103.04x | 11.50x | 75.02x |
TruAlt Bioenergy IPO Allotment Chances
Retail, SHNI, and BHNI chances based on application subscription
TruAlt Bioenergy IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.
| Category | Subscription (Apps) | Allotment Chances |
|---|---|---|
| Retail | 10.04x | 1 in 10 |
| SHNI (Rs 2L to Rs 10L) | 70.00x | 1 in 70 |
| BHNI (above Rs 10L) | 24.11x | 1 in 24 |
Chances use application subscription (how many bids came in), not share or amount figures. If you get allotment, you get at least one lot. Higher subscription means lower chance per PAN.
Check the TruAlt Bioenergy IPO Allotment Status page from 30 September 2025 for your result.
TruAlt Bioenergy IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 496.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 167.86 Cr | Rs 27,723.02 Cr | 165.16x |
| FII | - | Rs 4,078.26 Cr | - |
| DFI | - | Rs 16,097.57 Cr | - |
| Mutual Funds | - | Rs 688.36 Cr | - |
| Other | - | Rs 6,858.83 Cr | - |
| NII | Rs 125.89 Cr | Rs 12,971.93 Cr | 103.04x |
| bNII (above Rs 10L) | Rs 83.93 Cr | Rs 9,955.47 Cr | 118.62x |
| Corporate | - | Rs 57.96 Cr | - |
| Individual | - | Rs 9,404.76 Cr | - |
| Other | - | Rs 492.75 Cr | - |
| sNII (Rs 2L to Rs 10L) | Rs 41.96 Cr | Rs 3,016.46 Cr | 71.88x |
| Corporate | - | Rs 4.28 Cr | - |
| Individual | - | Rs 2,871.76 Cr | - |
| Other | - | Rs 140.42 Cr | - |
| Retail | Rs 293.75 Cr | Rs 3,377.97 Cr | 11.50x |
| Cut-off price | - | Rs 2,702.72 Cr | - |
| Fixed price | - | Rs 675.25 Cr | - |
| Total | Rs 587.50 Cr | Rs 44,072.91 Cr | 75.02x |
TruAlt Bioenergy IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 33,84,195 | 4,539 | 0.00x |
| FII | - | 67 | - |
| DFI | - | 65 | - |
| Mutual Funds | - | 3,350 | - |
| Other | - | 1,057 | - |
| NII | 6,043 | 2,38,117 | 39.40x |
| bNII (above Rs 10L) | 4,029 | 97,129 | 24.11x |
| Corporate | - | 572 | - |
| Individual | - | 91,724 | - |
| Other | - | 4,833 | - |
| sNII (Rs 2L to Rs 10L) | 2,014 | 1,40,988 | 70.00x |
| Corporate | - | 186 | - |
| Individual | - | 1,34,160 | - |
| Other | - | 6,642 | - |
| Retail | 1,97,411 | 19,81,482 | 10.04x |
| Cut-off price | - | 15,70,795 | - |
| Fixed price | - | 4,10,687 | - |
| Total | 35,87,649 | 22,24,138 | 0.62x |
What Do These Subscription Numbers Mean?
75.02x overall by shares means bids covered about 75 times the shares on offer. Allotment chances depend on applications in each category.
QIB at 165.16x by shares shows institutional demand from mutual funds, FIIs, and banks.
NII covers bids above Rs 2 lakh (39.40x by applications). Split: SHNI 70.00x, BHNI 24.11x by applications. SHNI and BHNI allotment is by lottery.
At 10.04x subscription by applications, about 1 in 10 retail applicants may get allotment (~10% chance per application). Retail allotment is also by lottery.
TruAlt Bioenergy IPO GMP After Subscription
GMP for TruAlt Bioenergy IPO stands at Rs 90.00 today, giving an estimated listing price of Rs 586.00 per share.
A subscription of 75.02x combined with a GMP of 18.15% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.
Track live GMP on the TruAlt Bioenergy IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
TruAlt Bioenergy IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 25 September 2025 |
| IPO Close Date | 29 September 2025 |
| Allotment Date | 30 September 2025 |
| Refund Initiation | 1 October 2025 |
| Share Credit to Demat | 1 October 2025 |
| Listing Date | 3 October 2025 |
| Minimum Investment | Rs 14,880.00 |
| Lot Size | 30 shares |
About TruAlt Bioenergy IPO
No company information available
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors (SHNI & BHNI)
Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.
Retail - Retail Individual Investors
Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.
TruAlt Bioenergy IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
TruAlt Bioenergy IPO Details
Issue size, price, financials, and company info
TruAlt Bioenergy IPO GMP
Live grey market premium and listing estimate
TruAlt Bioenergy IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
TruAlt Bioenergy IPO Allotment
Allotment date, chances, and check by PAN
TruAlt Bioenergy IPO Review
SWOT, strengths, risks, and IPO review
TruAlt Bioenergy IPO FAQ
Common questions on dates, GMP, and allotment
TruAlt Bioenergy IPO Registrar
Registrar website and how to check allotment
TruAlt Bioenergy IPO Timeline
Open, close, allotment, and listing dates
TruAlt Bioenergy IPO News
Updates, blogs, and latest IPO news
TruAlt Bioenergy IPO Subscription FAQs
What is TruAlt Bioenergy IPO subscription status today?
TruAlt Bioenergy IPO subscription closed on 29 September 2025 with overall subscription of 75.02x (by shares) as of 27 August 2026, 4:32 AM IST. QIB 165.16x, NII 39.40x, Retail 10.04x.
What is the overall subscription of TruAlt Bioenergy IPO?
TruAlt Bioenergy IPO is subscribed 75.02x overall by shares at close on 29 September 2025. QIB 165.16x, NII 39.40x, and Retail 10.04x.
What is TruAlt Bioenergy IPO QIB subscription?
TruAlt Bioenergy IPO QIB (Qualified Institutional Buyers) subscription is 165.16x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is TruAlt Bioenergy IPO Retail subscription?
TruAlt Bioenergy IPO Retail subscription is 10.04x by applications. Retail bids are up to Rs 2 lakh per PAN.
What is TruAlt Bioenergy IPO NII, SHNI, and BHNI subscription?
TruAlt Bioenergy IPO NII subscription is 39.40x by applications. NII is bids above Rs 2 lakh, split into SHNI (Rs 2L to Rs 10L) at 70.00x and BHNI (above Rs 10L) at 24.11x.
What are TruAlt Bioenergy IPO retail allotment chances?
At 10.04x subscription by applications, about 1 in 10 retail applicants may get allotment (~10% chance per application). Allotment is by lottery. Share subscription was 11.50x. Allotment chances use applications, not share volume.
What are TruAlt Bioenergy IPO SHNI allotment chances?
At 70.00x subscription by applications, about 1 in 70 SHNI applicants may get allotment (~1% chance per application). Allotment is by lottery. Share subscription was 71.88x. Allotment chances use applications, not share volume.
What are TruAlt Bioenergy IPO BHNI allotment chances?
At 24.11x subscription by applications, about 1 in 24 BHNI applicants may get allotment (~4% chance per application). Allotment is by lottery. Share subscription was 118.62x. Allotment chances use applications, not share volume.
When is TruAlt Bioenergy IPO allotment date?
TruAlt Bioenergy IPO allotment date is 30 September 2025. Check TruAlt Bioenergy IPO Allotment Status on IPOwiz from that day using your PAN.
When does TruAlt Bioenergy IPO subscription close?
TruAlt Bioenergy IPO subscription closed on 29 September 2025. No new applications are accepted after the close.
What is TruAlt Bioenergy IPO GMP today?
TruAlt Bioenergy IPO GMP is ₹90 today (+18.15% over issue price ₹496). See live GMP on the TruAlt Bioenergy IPO GMP Today page.
What is TruAlt Bioenergy IPO issue price and lot size?
TruAlt Bioenergy IPO issue price is ₹496 per share. Lot size is 30 shares. Minimum investment is ₹14,880 per lot. Issue size: ₹839.28 Cr.
When is TruAlt Bioenergy IPO listing date?
TruAlt Bioenergy IPO listing date is 3 October 2025 on NSE and BSE. Allotment is on 30 September 2025.
How does subscription affect TruAlt Bioenergy IPO allotment?
In TruAlt Bioenergy IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At 75.02x overall, competition is very high.
For allotment results from 30 September 2025, visit the TruAlt Bioenergy IPO Allotment Status page. For listing day updates on 3 October 2025, download the IPOwiz App.
Sources
We match TruAlt Bioenergy IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.